Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'BLEEHEN NM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jayasundar, R; Hall, LD; Bleehen, NM
      RF coils for combined MR and hyperthermia studies: I. Hyperthermia applicator as an MR coil

      MAGNETIC RESONANCE IMAGING
    2. Jayasundar, R; Hall, LD; Bleehen, NM
      RF coils for combined MR and hyperthermia studies: II. MR coil as an hyperthermic applicator

      MAGNETIC RESONANCE IMAGING
    3. Jayasundar, R; Honess, D; Hall, LD; Bleehen, NM
      Simultaneous evaluation of the effects of RF hyperthermia on the intra- and extracellular tumor pH

      MAGNETIC RESONANCE IN MEDICINE
    4. Mead, GM; Bleehen, NM; Gregor, A; Bullimore, J; Murrell, DS; Rampling, RP; Roberts, JT; Glaser, MG; Lantos, P; Ironside, JW; Moss, TH; Brada, M; Whaley, JB; Stenning, SP
      A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma - Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy

      CANCER
    5. Jayasundar, R; Hall, ED; Bleehen, NM
      Magnetic resonance, hyperthermia and oncology

      CURRENT SCIENCE
    6. Twelves, CJ; Gardner, C; Flavin, A; Sludden, J; Dennis, I; de Bono, J; Beale, P; Vasey, P; Hutchison, C; Macham, MA; Rodriguez, A; Judson, I; Bleehen, NM
      Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II

      BRITISH JOURNAL OF CANCER
    7. FORD J; OSBORN C; BARTON T; BLEEHEN NM
      A PHASE-I STUDY OF INTRAVENOUS RMP-7 WITH CARBOPLATIN IN PATIENTS WITH PROGRESSION OF MALIGNANT GLIOMA

      European journal of cancer
    8. MIDDLETON MR; LUNN JM; MORRIS C; RUSTIN G; WEDGE SR; BRAMPTON MH; LIND MJ; LEE SM; NEWELL DR; BLEEHEN NM; NEWLANDS ES; CALVERT AH; MARGISON GP; THATCHER N
      O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA

      British Journal of Cancer
    9. HAWKINS RE; RUSSELL SJ; MARCUS R; ASHWORTH LJ; BRISSNIK J; ZHANG J; WINTER G; BLEEHEN NM; STEVENSON F; HAMBLIN T; OSCIER D; ZHU DL; KING C; KUMAR S; THOMPSETT A; STEVENSON GT
      A PILOT-STUDY OF IDIOTYPIC VACCINATION FOR FOLLICULAR B-CELL LYMPHOMAUSING A GENETIC APPROACH

      Human gene therapy
    10. JAYASUNDAR R; HALL LD; BLEEHEN NM
      THE EFFECTS OF ANESTHESIA AND PHYSICAL RESTRAINT ON INTRACELLULAR ANDEXTRACELLULAR TUMOR PH, TUMOR TEMPERATURE AND BIOENERGETICS IN MURINERIF-1 TUMORS

      Magnetic resonance imaging
    11. BOWER M; NEWLANDS ES; BLEEHEN NM; BRADA M; BEGENT RJH; CALVERT H; COLQUHOUN I; LEWIS P; BRAMPTON MH
      MULTICENTER CRC PHASE-II TRIAL OF TEMOZOLOMIDE IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA

      Cancer chemotherapy and pharmacology
    12. BOOTE DJ; DENNIS IF; TWENTYMAN PR; OSBORNE RJ; LABURTE C; HENSEL S; SMYTH JF; BRAMPTON MH; BLEEHEN NM
      PHASE-I STUDY OF ETOPOSIDE WITH SDZ PSC 833 AS A MODULATOR OF MULTIDRUG-RESISTANCE IN PATIENTS WITH CANCER

      Journal of clinical oncology
    13. GIRLING DJ; THATCHER N; CLARK PI; HOPWOOD P; TWIDDY S; STEPHENS RJ; BAILEY AJ; MACHIN D; BLEEHEN NM; BOLGER JJ; CONNOLLY CK; HASLETON PS; MACBETH FR; MOGHISSI K; SAUNDERS MI; WHITE RJ; ALCOCK S; BURT H; CROSSLEY E; DECKER E; ENGLISH J; FOSTER G; HANNIGAN K; HERON D; HUTCHINSON J; LOMAX L; MERCER V; PAGE S; ROTHWELL T; STAINES K; TAYLORNEAL P; TURNBALL V; AXFORD AT; EARL HM; GLAHOLM J; FALK SJ; GRAHAM JD; JONES DK; COOMBES RC; EPSTEIN RJ; HANHAM I; LOWDELL CP; NEWLANDS E; SMITH DB; COOKSON JB; ANDERSON H; GRIBBIN HR; SINCLAIR DJM; CARMICHAEL J; CHAN SYT; JOHNSTON IDA; MORGAN SA; DUNN KS; MANIFOLD IH; RADSTONE DJ; LAMONT A; ROBINSON ACR; BISSETT D; NICOLSON MC; TANG OT; SINNAMON DG; VARGHESE G; BIBBY RJ; OREILLY JF; BATH JCJ; BREDIN CP; STEWART SJ; WHILLIS D; WILTSHIRE CR; MCILLMURRAY MB; BOND MG; WARDMAN AG; BOZZINO JM; FERGUSON GC; MACMILLAN CH; SUGDEN EM; TALBOT DC; QUIGLEY IG; WEATHERSTONE RM; VEALE D; OREGAN PF
      COMPARISON OF ORAL ETOPOSIDE AND STANDARD INTRAVENOUS MULTIDRUG CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - A STOPPED MULTICENTER RANDOMIZED TRIAL

      Lancet
    14. BLEEHEN NM; GIRLING DJ; HOPWOOD P; LALLEMAND G; MACHIN D; STEPHENS RJ; BAILEY AJ
      RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS (VOL 73, PG 406, 1996)

      British Journal of Cancer
    15. STEPHENS RJ; GIRLING DJ; BLEEHEN NM; MOGHISSI K; YOSEF HMA; MACHIN D
      THE ROLE OF POSTOPERATIVE RADIOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A MULTICENTER RANDOMIZED TRIAL IN PATIENTS WITH PATHOLOGICALLY STAGED T1-2N1-2,M(0) DISEASE

      British Journal of Cancer
    16. HONESS DJ; KITAMOTO Y; RAMPLING MR; BLEEHEN NM
      NICOTINAMIDE AND PENTOXIFYLLINE INCREASE HUMAN-LEUKOCYTE FILTERABILITY - A POSSIBLE MECHANISM FOR REDUCTION OF ACUTE-HYPOXIA

      British Journal of Cancer
    17. BLEEHEN NM; GIRLING DJ; HOPWOOD P; LALLEMAND G; MACHIN D; STEPHENS RJ; BAILEY AJ
      RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS

      British Journal of Cancer
    18. REEVE JG; MORGAN J; CLARK PMS; BLEEHEN NM
      INSULIN-LIKE GROWTH-FACTOR (IGF) AND IGF BINDING-PROTEINS IN GROWTH-HORMONE DYSREGULATION AND ABNORMAL GLUCOSE-TOLERANCE IN SMALL-CELL LUNG-CANCER PATIENTS

      European journal of cancer
    19. BLEEHEN NM; NEWLANDS ES; LEE SM; THATCHER N; SELBY P; CALVERT AH; RUSTIN GJS; BRAMPTON M; STEVENS MFG
      CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATICMELANOMA

      Journal of clinical oncology
    20. HONESS DJ; ANDREWS MS; WARD R; BLEEHEN NM
      PENTOXIFYLLINE INCREASES RIF-1 TUMOR PO(2) IN A MANNER COMPATIBLE WITH ITS ABILITY TO INCREASE RELATIVE TUMOR PERFUSION

      Acta oncologica
    21. FREW DG; DOBSON JM; STENNING SP; BLEEHEN NM
      RESPONSE OF 145 SPONTANEOUS CANINE HEAD AND NECK TUMORS TO RADIATION VERSUS RADIATION PLUS MICROWAVE HYPERTHERMIA - RESULTS OF A RANDOMIZEDPHASE-III CLINICAL-STUDY

      International journal of hyperthermia
    22. REEVE JG; GUADANO A; XIONG JY; MORGAN J; BLEEHEN NM
      DIMINISHED EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-5 AND ACTIVATION OF IGF-I-MEDIATED AUTOCRINE GROWTH IN SIMIAN-VIRUS 40-TRANSFORMED HUMAN FIBROBLASTS

      The Journal of biological chemistry
    23. KERR DJ; RUSTIN GJ; KAYE SB; SELBY P; BLEEHEN NM; HARPER P; BRAMPTON MH
      PHASE-II TRIALS OF RHIZOXIN IN ADVANCED OVARIAN, COLORECTAL AND RENAL-CANCER

      British Journal of Cancer
    24. BLEEHEN NM; NEWMAN HVF; RAMPLING RP; RAMSAY JR; ROBERTS JT; BEDFORD P; NETHERSELL ABW
      A PHASE-II STUDY OF ORAL PIRITREXIM IN RECURRENT HIGH-GRADE (III, IV)GLIOMA

      British Journal of Cancer
    25. LAURENCE VM; WARD R; DENNIS IF; BLEEHEN NM
      CARBOGEN BREATHING WITH NICOTINAMIDE IMPROVES THE OXYGEN STATUS OF TUMORS IN PATIENTS

      British Journal of Cancer
    26. HONESS DJ; BLEEHEN NM
      PERFUSION CHANGES IN THE RIF-1 TUMOR AND NORMAL-TISSUES AFTER CARBOGEN AND NICOTINAMIDE, INDIVIDUALLY AND COMBINED

      British Journal of Cancer
    27. JEBB SA; OSBORNE RJ; DIXON AK; BLEEHEN NM; ELIA M
      MEASUREMENTS OF RESTING ENERGY-EXPENDITURE AND BODY-COMPOSITION BEFORE AND AFTER TREATMENT OF SMALL-CELL LUNG-CANCER

      Annals of oncology
    28. STEPHENS RJ; GIRLING DJ; MACHIN D; THATCHER N; BLEEHEN NM; BOLGER JJ; CLARK PI; HASLETON PS; HOPWOOD P; MACBETH FR; MOGHISSI K; SAUNDERS MI; WHITE RJ
      TREATMENT-RELATED DEATHS IN SMALL-CELL LUNG-CANCER TRIALS - CAN PATIENTS AT RISK BE IDENTIFIED

      Lung cancer
    29. BLEEHEN NM; BALL D; BELANI CP; BISHOP J; DOUILLARD JY; COX JD; JOHNSON DH; LECHEVALIER T; SAUNDERS MI; SHAW E; SCHAAKEKONING C; TANNOCK I; TROVO M; TURRISI AT; VANHOUTTE P
      COMBINED RADIATION AND CHEMOTHERAPY FOR UNRESECTABLE NONSMALL CELL LUNG-CARCINOMA

      Lung cancer
    30. FALK SJ; RAMSAY JR; WARD R; MILES K; DIXON AK; BLEEHEN NM
      BW12C PERTURBS NORMAL AND TUMOR-TISSUE OXYGENATION AND BLOOD-FLOW IN MAN

      Radiotherapy and oncology
    31. SMITH PJ; SOUES S; GOTTLIEB T; FALK SJ; WATSON JV; OSBORNE RJ; BLEEHEN NM
      ETOPOSIDE-INDUCED CELL-CYCLE DELAY AND ARREST-DEPENDENT MODULATION OFDNA TOPOISOMERASE-II IN SMALL-CELL LUNG-CANCER CELLS

      British Journal of Cancer
    32. BLEEHEN NM; CALVERT AH; LEE SM; HARPER P; KAYE SB; JUDSON I; BRAMPTON M
      A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-II TRIAL OF CB10-277 GIVEN BY 24-HOUR INFUSION FOR MALIGNANT-MELANOMA

      British Journal of Cancer
    33. BLEEHEN NM; GIRLING DJ; GREGOR A; LEONARD RCF; MACHIN D; MCKENZIE CG; MORGAN DAL; SMYTH JF; SPITTLE MF; STEPHENS RJ; YOSEF HMA; BOLGER JJ; CLARK PI; HASLETON PS; HOPWOOD P; MACBETH FR; MOGHISSI K; SAUNDERS MI; THATCHER N; WHITE RJ
      CAN LONG-TERM SURVIVAL BE IMPROVED IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND GOOD PERFORMANCE STATUS

      British Journal of Cancer
    34. REEVE JG; BLEEHEN NM
      [D-ARG(1), D-PHE(5), D-TRP(7,9), LEU(11)] SUBSTANCE-P INDUCES APOPTOSIS IN LUNG-CANCER CELL-LINES IN-VITRO

      Biochemical and biophysical research communications
    35. REEVE JG; SCHWANDER J; BLEEHEN NM
      IGFBP-2 - AN IMPORTANT REGULATOR OF INSULIN-LIKE GROWTH-FACTOR ACTIONIN HUMAN LUNG-TUMORS

      Growth regulation
    36. HONESS DJ; DENNIS IF; BLEEHEN NM
      PENTOXIFYLLINE - ITS PHARMACOKINETICS AND ABILITY TO IMPROVE TUMOR PERFUSION AND RADIOSENSITIVITY IN MICE

      Radiotherapy and oncology
    37. HONESS DJ; BLEEHEN NM
      EFFECTS OF THE RADIOSENSITISING AGENT NICOTINAMIDE ON RELATIVE TISSUEPERFUSION AND KIDNEY-FUNCTION IN C3H MICE

      Radiotherapy and oncology
    38. REEVE JG; MORGAN J; SCHWANDER J; BLEEHEN NM
      ROLE FOR MEMBRANE AND SECRETED INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-2 IN THE REGULATION OF INSULIN-LIKE GROWTH-FACTOR ACTION IN LUNG-TUMORS

      Cancer research
    39. BLEEHEN NM; GIRLING DJ; MACHIN D; STEPHENS RJ; BARLEY VL; BULLIMORE JA; WHITE RJ; BLEEHAN NM; WILLIAMS MV; BREDIN CP; DAVIDSON AR; WILLIAMS TJ; ASH DV; CLOSE HJ; JOSLIN CA; MUERS MF; STONE J; ASHFORD RF; DISCHE S; DUNPHY EP; FERMONT DC; GROSCH E; MAHER EJ; SAUNDERS MI; ADAM RJ; ALCOCK CJ; BENSON MK; HOPKIN JM; LANE DJ; HUNTER AM
      A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .1. SURVIVAL AND PROGNOSTIC FACTORS

      British Journal of Cancer
    40. BLEEHEN NM; GIRLING DJ; MACHIN D; STEPHENS RJ; HARTLEY JPR; HODSON NJ; TURTON CW; BARLEY VL; BULLIMORE JA; WHITE RJ; BLEEHEN NM; WILLIAMS MV; BREDIN CP; DAVIDSON AR; WILLIAMS TJ; ASH DV; CLOSE HJ; JOSLIN CA; MUERS MF; STONE J; ASHFORD RF; DISCHE S; DUNPHY EP; FERMONT DC; GROSCH E; MAHER EJ; SAUNDERS MI; ADAM RJ; ALCOCK CJ; BENSON MK; HOPKIN JM; LANE DJ; HUNTER AM
      A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .2. QUALITY-OF-LIFE

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 14:07:05